ArticleBMC psychiatry2025
Prevalence of migraine among adults with mood disorders: a Saudi cross-sectional study.
Article in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMigraine is characterized by recurrent headaches and frequently coexists with depressive and bipolar disorders, exacerbating disability and complicating management. Data on this association in Saudi Arabia remain limited, however.
objectivesThis study aims to investigate how mood disorders and migraine occur together in the Saudi context and understand the extent of disability that migraine may cause in patients with mood disorders.
methodsA cross-sectional study was conducted involving adult patients with mood disorders at a tertiary hospital in Riyadh, Saudi Arabia. Participants were recruited through convenience sampling. The research instrument consisted of a questionnaire developed by the research team to assess sociodemographic factors, along with the Arabic version of the Migraine Screen Questionnaire (MS-Q) for migraine screening and the Arabic version of the Migraine Disability Assessment Scale (MIDAS) to quantify migraine-related disability.
resultsA total of 206 participants were included, 10.68% of whom had a prior diagnosis of migraine and 20.87% screened positive for migraine on the MS-Q. The average MS-Q score was 1.48 ± 1.86 and MIDAS score 6.81 ± 19.3, indicating mild to moderate disability. Among those with migraine, 31.25% had severe migraine-related disability. The multivariate analysis identified female sex, psychiatric comorbidity, sleep quality, and family history of migraine as significant predictors for migraine. There was no correlation with age, income, employment status, snoring, or mood disorder type.
conclusionThe results confirm that migraine is a prevalent and disabling comorbidity among individuals with mood disorders, with female sex, family history of migraine, poor sleep quality, and psychiatric comorbidities increasing the risk of migraine. Thus, routine migraine screening in psychiatric settings may improve diagnosis, management, and patient outcomes. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.